Cargando…

A Conformation Variant of p53 Combined with Machine Learning Identifies Alzheimer Disease in Preclinical and Prodromal Stages

Early diagnosis of Alzheimer’s disease (AD) is a crucial starting point in disease management. Blood-based biomarkers could represent a considerable advantage in providing AD-risk information in primary care settings. Here, we report new data for a relatively unknown blood-based biomarker that holds...

Descripción completa

Detalles Bibliográficos
Autores principales:	Abate, Giulia, Vezzoli, Marika, Polito, Letizia, Guaita, Antonio, Albani, Diego, Marizzoni, Moira, Garrafa, Emirena, Marengoni, Alessandra, Forloni, Gianluigi, Frisoni, Giovanni B., Cummings, Jeffrey L., Memo, Maurizio, Uberti, Daniela
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7823360/ https://www.ncbi.nlm.nih.gov/pubmed/33375220 http://dx.doi.org/10.3390/jpm11010014

Ejemplares similares

A Simple Blood Test, Such as Complete Blood Count, Can Predict Calcification Grade of Abdominal Aortic Aneurysm
por: Vezzoli, Marika, et al.
Publicado: (2017)

Early prediction of in-hospital death of COVID-19 patients: a machine-learning model based on age, blood analyses, and chest x-ray score
por: Garrafa, Emirena, et al.
Publicado: (2021)

The pleiotropic role of p53 in functional/dysfunctional neurons: focus on pathogenesis and diagnosis of Alzheimer’s disease
por: Abate, Giulia, et al.
Publicado: (2020)

Mitochondrial Dysfunction in Peripheral Blood Mononuclear Cells as Novel Diagnostic Tools for Non-Alcoholic Fatty Liver Disease: Visualizing Relationships with Known and Potential Disease Biomarkers
por: Garrafa, Emirena, et al.
Publicado: (2023)

Impact of COVID-19 on Alzheimer’s Disease Risk: Viewpoint for Research Action
por: Abate, Giulia, et al.
Publicado: (2020)

A Novel Study and Meta-Analysis of the Genetic Variation of the Serotonin Transporter Promoter in the Italian Population Do Not Support a Large Effect on Alzheimer's Disease Risk
por: Polito, Letizia, et al.
Publicado: (2011)

Brain aging and dementia during the transition from late adulthood to old age: design and methodology of the “Invece.Ab” population-based study
por: Guaita, Antonio, et al.
Publicado: (2013)

A polymorphic variant of the insulin-like growth factor 1 (IGF-1) receptor correlates with male longevity in the Italian population: a genetic study and evaluation of circulating IGF-1 from the "Treviso Longeva (TRELONG)" study
por: Albani, Diego, et al.
Publicado: (2009)

ELM: A New, Simple, and Economic Assay to Measure Motility of Lymphatic Endothelial Cells
por: Torri, Fabio, et al.
Publicado: (2017)

Electromagnetic signatures of the preclinical and prodromal stages of Alzheimer’s disease
por: Nakamura, Akinori, et al.
Publicado: (2018)

Circuit imaging biomarkers in preclinical and prodromal Parkinson's disease
por: Meles, Sanne K., et al.
Publicado: (2021)

Electrochemical detection of different p53 conformations by using nanostructured surfaces
por: Tonello, Sarah, et al.
Publicado: (2019)

The Trial-Ready Cohort for Preclinical/Prodromal Alzheimer’s Disease (TRC-PAD) Project: An Overview
por: Aisen, P.S., et al.
Publicado: (2020)

When fear backfires: Emergency department accesses during the Covid-19 pandemic
por: Garrafa, Emirena, et al.
Publicado: (2020)

Nutrition and AGE-ing: Focusing on Alzheimer's Disease
por: Abate, Giulia, et al.
Publicado: (2017)

Cognitive markers of preclinical and prodromal Alzheimer's disease in Down syndrome
por: Startin, Carla M., et al.
Publicado: (2019)

Less is more: an ecological and economic point of view on appropriate use of lab testing for COVID patients
por: Signorini, Simona Giulia, et al.
Publicado: (2021)

NF-κB/c-Rel deficiency causes Parkinson’s disease-like prodromal symptoms and progressive pathology in mice
por: Parrella, Edoardo, et al.
Publicado: (2019)

Conformational altered p53 affects neuronal function: relevance for the response to toxic insult and growth-associated protein 43 expression
por: Buizza, L, et al.
Publicado: (2013)

Clinical Laboratory Automation: A Case Study
por: Archetti, Claudia, et al.
Publicado: (2017)

Neuropsychological assessment in preclinical and prodromal Alzheimer disease: a global perspective
por: Watermeyer, Tamlyn, et al.
Publicado: (2019)

The use of hippocampal grading as a biomarker for preclinical and prodromal Alzheimer's disease
por: Morrison, Cassandra, et al.
Publicado: (2023)

Conformational Altered p53 as an Early Marker of Oxidative Stress in Alzheimer's Disease
por: Buizza, Laura, et al.
Publicado: (2012)

3D brain tissue physiological model with co-cultured primary neurons and glial cells in hydrogels
por: Raimondi, Ilaria, et al.
Publicado: (2020)

Induced pluripotent stem cell-based organ-on-a-chip as personalized drug screening tools: A focus on neurodegenerative disorders
por: Fanizza, Francesca, et al.
Publicado: (2022)

The Trial-Ready Cohort for Preclinical and Prodromal Alzheimer’s Disease (TRC-PAD): Experience from the First 3 Years
por: Walter, S., et al.
Publicado: (2020)

Gamma-oryzanol Prevents LPS-induced Brain Inflammation and Cognitive Impairment in Adult Mice
por: Mastinu, Andrea, et al.
Publicado: (2019)

Cognitive indicators of transition to preclinical and prodromal stages of Alzheimer's disease in Down syndrome
por: Hartley, Sigan L., et al.
Publicado: (2020)

Sleep and Tau Pathology in Vietnam War Veterans with Preclinical and Prodromal Alzheimer’s Disease
por: Andrews, Murray, et al.
Publicado: (2021)

Frontotemporal Lobar Degeneration and MicroRNAs
por: Piscopo, Paola, et al.
Publicado: (2016)

The Bright Side of Psychedelics: Latest Advances and Challenges in Neuropharmacology
por: Mastinu, Andrea, et al.
Publicado: (2023)

Unsupervised [(18)F]Flortaucipir cutoffs for tau positivity and staging in Alzheimer’s disease
por: Quattrini, Giulia, et al.
Publicado: (2023)

Prodromes and Preclinical Detection of Brain Diseases: Surveying the Ethical Landscape of Predicting Brain Health
por: Ahlgrim, Nathan S., et al.
Publicado: (2019)

Recruitment into the Alzheimer Prevention Trials (APT) Webstudy for a Trial-Ready Cohort for Preclinical and Prodromal Alzheimer’s Disease (TRC-PAD)
por: Walter, S., et al.
Publicado: (2020)

Beyond Chronological Age: Frailty and Multimorbidity Predict In-Hospital Mortality in Patients With Coronavirus Disease 2019
por: Marengoni, Alessandra, et al.
Publicado: (2020)

Immunoconjugates for Osteosarcoma Therapy: Preclinical Experiences and Future Perspectives
por: Mercatelli, Daniele, et al.
Publicado: (2018)

The effect of diagnostic criteria on outcome measures in preclinical and prodromal Alzheimer's disease: Implications for trial design
por: Bertens, Daniela, et al.
Publicado: (2017)

MRI-based Alzheimer’s disease-resemblance atrophy index in the detection of preclinical and prodromal Alzheimer’s disease
por: Liu, Wanting, et al.
Publicado: (2021)

Redox Homeostasis and Natural Dietary Compounds: Focusing on Antioxidants of Rice (Oryza sativa L.)
por: Rungratanawanich, Wiramon, et al.
Publicado: (2018)

Development of an Induced Pluripotent Stem Cell-Based Liver-on-a-Chip Assessed with an Alzheimer’s Disease Drug
por: Fanizza, Francesca, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_t0au9rdbci2j2u28ip4sgqkh01